Ganciclovir Population Pharmacokinetics in Neonates Following Intravenous Administration of Ganciclovir and Oral Administration of a Liquid Valganciclovir Formulation-Reference-Cited by-同舟云学术

Ganciclovir Population Pharmacokinetics in Neonates Following Intravenous Administration of Ganciclovir and Oral Administration of a Liquid Valganciclovir Formulation

Published:2007-03-28 Issue:6 Volume:81 Page:867-872
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Acosta E P,Brundage R C,King J R,Sánchez P J,Sood S,Agrawal V,Homans J,Jacobs R F,Lang D,Romero J R,Griffin J,Cloud G,Whitley R,Kimberlin D W

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference14 articles.

1. DEVELOPMENT OF A VACCINE AGAINST MENTAL RETARDATION CAUSED BY CYTOMEGALOVIRUS INFECTION IN UTERO

2. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection

3. Congenital Cytomegalovirus Infection and Sensorineural Hearing Loss

4. Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed?

5. Infectious Diseases Society of America and Centers for Disease Control: Summary of a Workshop on Surveillance for Congenital Cytomegalovirus Disease

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacology of antiinfective drugs;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Assessment of patients’ characteristics associated with the efficacy and safety of oral valganciclovir treatment for infants with symptomatic congenital cytomegalovirus disease;Journal of Infection and Chemotherapy;2024-10

3. Pharmacokinetic and Pharmacodynamic Assessment of Valganciclovir in Infants With Congenital Cytomegalovirus Infection;Therapeutic Drug Monitoring;2024-09-04

4. Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir;Pharmaceutics;2023-06-23

5. Optimizing ganciclovir and valganciclovir dosing regimens in pediatric patients with cytomegalovirus infection: a spotlight on therapeutic drug monitoring;Expert Review of Clinical Pharmacology;2023-02-23